150 related articles for article (PubMed ID: 3086877)
1. Analysis of the phorbol ester pharmacophore on protein kinase C as a guide to the rational design of new classes of analogs.
Wender PA; Koehler KF; Sharkey NA; Dell'Aquila ML; Blumberg PM
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4214-8. PubMed ID: 3086877
[TBL] [Abstract][Full Text] [Related]
2. Computer-assisted molecular modeling of tumor promoters: rationale for the activity of phorbol esters, teleocidin B, and aplysiatoxin.
Jeffrey AM; Liskamp RM
Proc Natl Acad Sci U S A; 1986 Jan; 83(2):241-5. PubMed ID: 3079908
[TBL] [Abstract][Full Text] [Related]
3. A receptor model for tumor promoters: rational superposition of teleocidins and phorbol esters.
Itai A; Kato Y; Tomioka N; Iitaka Y; Endo Y; Hasegawa M; Shudo K; Fujiki H; Sakai S
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3688-92. PubMed ID: 3131760
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of human monocyte oxidative burst and related cytotoxicity by tumor-promoting and non-tumor-promoting diterpene esters, indole alkaloids and polyacetate-type agents.
Keisari Y; Geva I; Flescher E; Goldin H; Lavie G
Int J Cancer; 1985 Oct; 36(4):467-72. PubMed ID: 3930412
[TBL] [Abstract][Full Text] [Related]
5. Receptors for the phorbol ester tumour promoters.
Blumberg PM; Leach KL; König B; Jeng AY; Sharkey NA
Ciba Found Symp; 1985; 116():205-23. PubMed ID: 4075903
[TBL] [Abstract][Full Text] [Related]
6. Activation of protein kinase C by tumor promoting phorbol esters, teleocidin and aplysiatoxin in the absence of added calcium.
Arcoleo JP; Weinstein IB
Carcinogenesis; 1985 Feb; 6(2):213-7. PubMed ID: 3156004
[TBL] [Abstract][Full Text] [Related]
7. Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation.
Endo Y; Takehana S; Ohno M; Driedger PE; Stabel S; Mizutani MY; Tomioka N; Itai A; Shudo K
J Med Chem; 1998 Apr; 41(9):1476-96. PubMed ID: 9554881
[TBL] [Abstract][Full Text] [Related]
8. Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells.
Jeng AY; Lichti U; Strickland JE; Blumberg PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5714-21. PubMed ID: 3931907
[TBL] [Abstract][Full Text] [Related]
9. Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor.
Friedman B; Frackelton AR; Ross AH; Connors JM; Fujiki H; Sugimura T; Rosner MR
Proc Natl Acad Sci U S A; 1984 May; 81(10):3034-8. PubMed ID: 6328489
[TBL] [Abstract][Full Text] [Related]
10. Effects of phorbol diesters and teleocidin on normal human platelets.
Cech P; Rosove MH; Harwig SS; Lehrer RI
Thromb Res; 1986 May; 42(3):383-96. PubMed ID: 2940726
[TBL] [Abstract][Full Text] [Related]
11. Structure/activity relationships of polyfunctional diterpenes of the tigliane type. A pharmacophore model for protein-kinase-C activators based on structure/activity studies and molecular modeling of the tumor promoters 12-O-tetradecanoylphorbol 13-acetate and 3-O-tetradecanoylingenol.
Krauter G; Von der Lieth CW; Schmidt R; Hecker E
Eur J Biochem; 1996 Dec; 242(2):417-27. PubMed ID: 8973661
[TBL] [Abstract][Full Text] [Related]
12. Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C.
Wender PA; Cribbs CM; Koehler KF; Sharkey NA; Herald CL; Kamano Y; Pettit GR; Blumberg PM
Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7197-201. PubMed ID: 3174627
[TBL] [Abstract][Full Text] [Related]
13. Studies on bioactive compounds. 13. Synthesis and lack of growth-inhibitory properties of cyclohexane-1,2,4-triol 1,2-diesters, which resemble ring C of the phorbol ester molecule.
Laughton CA; Dale IL; Gescher A
J Med Chem; 1989 Feb; 32(2):428-33. PubMed ID: 2913303
[TBL] [Abstract][Full Text] [Related]
14. Specific binding of phorbol ester tumor promoters to mouse tissues and cultured cells.
Blumberg PM; Delclos KB; Dunphy WG; Jaken S
Carcinog Compr Surv; 1982; 7():519-35. PubMed ID: 7039833
[TBL] [Abstract][Full Text] [Related]
15. [The active structure of tumor promoters].
Endo Y; Itai A; Shudo K; Fujiki H
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3365-75. PubMed ID: 3098181
[TBL] [Abstract][Full Text] [Related]
16. Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity.
Bögi K; Lorenzo PS; Szállási Z; Acs P; Wagner GS; Blumberg PM
Cancer Res; 1998 Apr; 58(7):1423-8. PubMed ID: 9537243
[TBL] [Abstract][Full Text] [Related]
17. Activation of protein kinase C and specific phosphorylation of a Mr 90,000 membrane protein of promotable BALB/3T3 and C3H/10T1/2 cells by tumor promoters.
Chida K; Hashiba H; Sasaki K; Kuroki T
Cancer Res; 1986 Mar; 46(3):1055-62. PubMed ID: 3080229
[TBL] [Abstract][Full Text] [Related]
18. Activation of calcium-activated, phospholipid-dependent protein kinase (protein kinase C) by new classes of tumor promoters: teleocidin and debromoaplysiatoxin.
Fujiki H; Tanaka Y; Miyake R; Kikkawa U; Nishizuka Y; Sugimura T
Biochem Biophys Res Commun; 1984 Apr; 120(2):339-43. PubMed ID: 6233970
[TBL] [Abstract][Full Text] [Related]
19. Diacylglycerols mimic phorbol diester induction of leukemic cell differentiation.
Ebeling JG; Vandenbark GR; Kuhn LJ; Ganong BR; Bell RM; Niedel JE
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):815-9. PubMed ID: 3156372
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane associated protein kinase C as receptor of diterpene ester co-carcinogens of the tumor promoter type and the phenotypic expression of tumors.
Hecker E
Arzneimittelforschung; 1985; 35(12A):1890-903. PubMed ID: 3006705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
